These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 11831203)

  • 41. Treating HIV in the developing world: getting ahead of the drug development curve.
    Ford N; Calmy A; von Schoen-Angerer T
    Drug Discov Today; 2007 Jan; 12(1-2):1-3. PubMed ID: 17198967
    [No Abstract]   [Full Text] [Related]  

  • 42. The fight against HIV/AIDS: opportunities and challenges.
    Lulseged S; Sanders E
    Ethiop Med J; 2002 Apr; 40 Suppl 1():2p. PubMed ID: 12802825
    [No Abstract]   [Full Text] [Related]  

  • 43. Cooperation forms to accelerate access to AIDS care in developing countries.
    AIDS Read; 2000 Jun; 10(6):339. PubMed ID: 10881360
    [No Abstract]   [Full Text] [Related]  

  • 44. The human right to health, national courts, and access to HIV/AIDS treatment: a case study from Venezuela.
    Torres MA
    Chic J Int Law; 2002; 3(1):105-14. PubMed ID: 15709302
    [No Abstract]   [Full Text] [Related]  

  • 45. Experts clash over likely impact of cheap AIDS drugs in Africa.
    Wadman M
    Nature; 2001 Apr; 410(6829):615-6. PubMed ID: 11287906
    [No Abstract]   [Full Text] [Related]  

  • 46. Antiretrovirals: reality or illusion?
    Mazin R; Zacarias F
    J Int Assoc Physicians AIDS Care; 1998 Oct; 4(10):28-9. PubMed ID: 11365958
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Access to essential medications for HIV/AIDS in South Africa.
    Andrews S
    S Afr Med J; 2001 May; 91(5):384-7. PubMed ID: 11455797
    [No Abstract]   [Full Text] [Related]  

  • 48. Universal access to HIV/AIDS treatment: challenges ahead.
    Satyanarayana K; Srivastava S
    Indian J Med Res; 2009 Dec; 130(6):671-4. PubMed ID: 20090125
    [No Abstract]   [Full Text] [Related]  

  • 49. Access to essential medicines: a Hobbesian social contract approach.
    Ashcroft RE
    Dev World Bioeth; 2005 May; 5(2):121-41. PubMed ID: 15842722
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The (political) economics of antiretroviral treatment in developing countries.
    Nattrass NJ
    Trends Microbiol; 2008 Dec; 16(12):574-9. PubMed ID: 18964022
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Equity and efficiency in scaling up access to HIV-related interventions in resource-limited settings.
    Cleary S
    Curr Opin HIV AIDS; 2010 May; 5(3):210-4. PubMed ID: 20539076
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [HIV-treatment. Interactions, compliance, prolonged adverse effects and global accessibility].
    Gerstoft J
    Ugeskr Laeger; 2000 Aug; 162(35):4639. PubMed ID: 10986887
    [No Abstract]   [Full Text] [Related]  

  • 53. Policy watch. Profitable pills.
    Gebbie KM
    AIDS Read; 2004 Mar; 14(3):106, 109. PubMed ID: 15067998
    [No Abstract]   [Full Text] [Related]  

  • 54. European Parliament supports treatment access in developing countries.
    James JS
    AIDS Treat News; 2001 Mar; (363):4-5. PubMed ID: 11547677
    [No Abstract]   [Full Text] [Related]  

  • 55. Simplifying and adapting antiretroviral treatment in resource-poor settings: a necessary step to scaling-up.
    Calmy A; Klement E; Teck R; Berman D; Pécoul B; Ferradini L
    AIDS; 2004 Dec; 18(18):2353-60. PubMed ID: 15622311
    [No Abstract]   [Full Text] [Related]  

  • 56. AIDS and property rights in Africa.
    Trotter G
    Health Care Ethics USA; 2001; 9(2):E2. PubMed ID: 16184688
    [No Abstract]   [Full Text] [Related]  

  • 57. World Trade Organization still threatens supply of affordable AIDS drugs.
    Hagmann M
    Bull World Health Organ; 2002; 80(9):762-3. PubMed ID: 12378300
    [No Abstract]   [Full Text] [Related]  

  • 58. Sustaining treatment costs: who will pay?
    Zewdie D; De Cock K; Piot P
    AIDS; 2007 Jul; 21 Suppl 4():S1-4. PubMed ID: 17620744
    [No Abstract]   [Full Text] [Related]  

  • 59. [HIV antiretroviral agents: new threats to accessibility in developing countries].
    Nau JY
    Rev Med Suisse; 2005 Dec; 1(45):2956. PubMed ID: 16425957
    [No Abstract]   [Full Text] [Related]  

  • 60. Antiretroviral therapy to treat and prevent HIV/AIDS in resource-poor settings.
    Garnett GP; Bartley L; Grassly NC; Anderson RM
    Nat Med; 2002 Jul; 8(7):651-4. PubMed ID: 12091892
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.